Much, if not all, long COVID appears to be driven by the virus persisting in the body. Formal proof remains elusive but here’s what the science shows.
- Senior Research Fellow, Burnet Institute
A promising collection of studies suggests taking antivirals such as Paxlovid during an infection could reduce the risk of developing long COVID.
Contact Michelle for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Melbourne, Australia
- X (formerly Twitter): @MJLScoullar
- Article Feed
- ORCID
- Joined
